Cardio Diagnostics Holdings (CDIO) Income from Continuing Operations (2021 - 2026)
Cardio Diagnostics Holdings' (CDIO) quarterly Income from Continuing Operations came in at -$1.5 million in Q2 2026, up 10.8% year-over-year from -$1.4 million in Q2 2025, and up 16.03% quarter-over-quarter from -$1.8 million in Q1 2026.
Analysis
Cardio Diagnostics Holdings (CDIO) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has disclosed Income from Continuing Operations across 6 years of filings, most recently posting -$1.5 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 10.8% year-over-year to -$1.5 million; the TTM figure through Jun 2026 stood at -$6.5 million (down 3.51% YoY), while the FY2025 annual figure was -$5.1 million, up 38.77% from the prior year.
- Income from Continuing Operations came in at -$1.5 million for Q2 2026 at Cardio Diagnostics Holdings, up from -$1.8 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of -$290055.0 in Q1 2022 to a low of -$4.2 million in Q1 2024.
- Average Income from Continuing Operations over 5 years is -$1.7 million, with a median of -$1.5 million recorded in 2024.
- Year-over-year, Income from Continuing Operations tumbled 211990.18% in 2022 and soared 67.98% in 2024.
- Over 5 years, Income from Continuing Operations stood at -$2.4 million in 2022, then soared by 41.59% to -$1.4 million in 2023, then dropped by 9.39% to -$1.5 million in 2024, then grew by 3.55% to -$1.5 million in 2025, then slipped by 2.46% to -$1.5 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$1.5 million in Q2 2026, -$1.8 million in Q1 2026, and -$1.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn | 574.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 75.03 Mn |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn | -15.74 Mn |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn | -10.50 Mn |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn | -12.91 Mn |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn | -19.27 Mn |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 15.90 Mn |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn | -9.08 Mn |
| 10 | Cardio Diagnostics Holdings | 6.04 Mn | 450,619.65 | - | -1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.79 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | -1.68 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -1.39 Mn |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -4.02 Mn |
| Mar 31, 2023 | -1.03 Mn |
| Dec 31, 2022 | -2.38 Mn |
| Sep 30, 2022 | -1.15 Mn |
| Jun 30, 2022 | -841,998.00 |
| Mar 31, 2022 | -290,055.00 |
| Dec 31, 2021 | -144,837.00 |
| Sep 30, 2021 | -721.00 |